Literature DB >> 30058202

Relaxometry and quantification in simultaneously acquired single and triple quantum filtered sodium MRI.

Wieland A Worthoff1, Aliaksandra Shymanskaya1,2, N Jon Shah1,2,3.   

Abstract

PURPOSE: Sodium imaging delivers valuable information about in vivo metabolism and pathophysiology. Image quantification can benefit the diagnosis and characterization of existing pathologies and the clinical course of a disease. An enhanced SISTINA sequence is proposed for sodium imaging and for the estimation of sodium tissue parameters for a 2-compartment model of the brain, such as relaxation times in intracellular space and tissue, intracellular volume fraction, and intracellular molar fraction. The aim of the research is to demonstrate how a 2-compartment model can be parameterized to sufficiently describe tissue sodium concentrations and dynamics by performing relaxometry with such a sequence.
METHODS: Multiple quantum filtered sodium signals were detected using an enhanced SISTINA sequence (consisting of 3 consecutive RF pulses) by placing a readout train between the first and second RF pulse, and 1 after the third pulse. Semiautomatic segmentation using singular value decomposition and manual segmentation was applied to the images.
RESULTS: Analysis was performed on 40 healthy volunteers in a 4T scanner, yielding bi-exponential relaxation times of brain tissue, intracellular sodium molar and volume fraction, intracellular sodium concentration, as well as sodium tissue concentration in the scope of a considered model. Two models with either purely mono-exponential or bi-exponential relaxing extracellular sodium were used with and without a potential contribution of triple quantum-filtered signal from extracellular space.
CONCLUSION: An estimation of relaxation properties and concentrations limited to the assumed model is possible from a single sequence. The achieved results agree well with those reported in literature.
© 2018 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  SISTINA; multiple quantum filtering; quantification; relaxometry; segmentation; sodium metabolic imaging

Year:  2018        PMID: 30058202     DOI: 10.1002/mrm.27387

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  4 in total

1.  Comparison of [18F]Fluoroethyltyrosine PET and Sodium MRI in Cerebral Gliomas: a Pilot Study.

Authors:  Aliaksandra Shymanskaya; Wieland A Worthoff; Gabriele Stoffels; Johannes Lindemeyer; Bernd Neumaier; Philipp Lohmann; Norbert Galldiks; Karl-Josef Langen; N Jon Shah
Journal:  Mol Imaging Biol       Date:  2020-02       Impact factor: 3.488

2.  Efficient 23 Na triple-quantum signal imaging on clinical scanners: Cartesian imaging of single and triple-quantum 23 Na (CRISTINA).

Authors:  Michaela A U Hoesl; Lothar R Schad; Stanislas Rapacchi
Journal:  Magn Reson Med       Date:  2020-05-28       Impact factor: 4.668

3.  Two Decades of Brain Tumour Imaging with O-(2-[18F]fluoroethyl)-L-tyrosine PET: The Forschungszentrum Jülich Experience.

Authors:  Alexander Heinzel; Daniela Dedic; Norbert Galldiks; Philipp Lohmann; Gabriele Stoffels; Christian P Filss; Martin Kocher; Filippo Migliorini; Kim N H Dillen; Stefanie Geisler; Carina Stegmayr; Antje Willuweit; Michael Sabel; Marion Rapp; Michael J Eble; Marc Piroth; Hans Clusmann; Daniel Delev; Elena K Bauer; Garry Ceccon; Veronika Dunkl; Jurij Rosen; Caroline Tscherpel; Jan-Michael Werner; Maximilian I Ruge; Roland Goldbrunner; Jürgen Hampl; Carolin Weiss Lucas; Ulrich Herrlinger; Gabriele D Maurer; Joachim P Steinbach; Jörg Mauler; Wieland A Worthoff; Bernd N Neumaier; Christoph Lerche; Gereon R Fink; Nadim Jon Shah; Felix M Mottaghy; Karl-Josef Langen
Journal:  Cancers (Basel)       Date:  2022-07-08       Impact factor: 6.575

4.  A novel gamma GLM approach to MRI relaxometry comparisons.

Authors:  Rohan Kapre; Junhan Zhou; Xinzhe Li; Laurel Beckett; Angelique Y Louie
Journal:  Magn Reson Med       Date:  2020-02-12       Impact factor: 4.668

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.